Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia

ClinicalTrials.gov ID: NCT00060892

Public ClinicalTrials.gov record NCT00060892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Leg Ischemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study was to assess the overall safety of different dose regimens of AMG0001 (HGF transferred via plasmid vector) as well as evaluate the improvement of blood perfusion in subjects with critical limb ischemia (CLI). This study also evaluated the improvement in wound healing without adverse effects on the quality of life, as well as the potential reduction of amputation, mortality and rest pain in the CLI population.

Study identification

NCT ID
NCT00060892
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnGes USA, Inc.
Industry
Enrollment
104 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2003 (Type not available)
Primary completion
May 2006 (Actual)
Completion
Jan 2007 (Actual)
Last update posted
Jan 11, 2008

2003 – 2007

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211 —
Central Arkansas Veteran's Healthcare System Little Rock Arkansas 72205 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Falk Cardiovascular Research Center Stanford California 94305 —
VA Medical Center Surgical Service (112) Washington D.C. District of Columbia 20422 —
Basptist Hospital Pensacola Florida 32501 —
University of South Florida College of Medicine Tampa Florida 33606 —
American Cardiovascular Research Institute Atlanta Georgia 30342 —
University of Chicago Hospitals Chicago Illinois 60637 —
The Care Group, LLC Indianapolis Indiana 46290 —
The Ochsner Heart and Vascular Institute Metairie Louisiana 70002 —
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407 —
Dartmouth - Hitchcock Medical Center Lebanon New Hampshire 03756 —
Diabetes Foot and Ankle Center New York New York 10003 —
NYPH-NY Weill Cornell Medical Center New York New York 10021 —
University of Rochester Rochester New York 14642 —
Pitt County Memorial Hospital Greenville North Carolina 27834 —
The Lindner Clinical Trial Center Cincinnati Ohio 45219 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Jobst Vascular Center Toledo Ohio 43606 —
Medical College of Ohio Toledo Ohio 43614 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Baylor College of Medicine Houston Texas 77030 —
Peripheral Vascular Associates San Antonio Texas 78215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00060892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2008 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00060892 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →